Skip to main content
. Author manuscript; available in PMC: 2013 Mar 3.
Published in final edited form as: J Health Care Poor Underserved. 2011 Nov;22(4):1179–1189. doi: 10.1353/hpu.2011.0127

Table 1.

Clinical Indications for the use of Medications for Cardiovascular Disease Prevention Included in this Analysis

  1. Aspirin or clopidogrel use in those with cardiovascular disease

  2. Beta-blocker use in those with a self-reported history of myocardial infarction

  3. ACE-I or ARB use in those with either a) diabetes or b) cardiovascular disease and either HTN or CKD

  4. Statin use in those with a) cardiovascular disease or diabetes and b) LDL-C >100 mg/dL

  5. Warfarin use in those with a self-reported history of atrial fibrillation

ACE-I = ace inhibitor, ARB = angiotensin receptor blocker, CKD = chronic kidney disease, HTN = hypertension, LDL-C = low density lipoprotein cholesterol

Cardiovascular disease defined as a self-reported history of myocardial infarction, stroke, coronary artery bypass surgery, percutaneous coronary intervention, carotid artery surgery or stenting, or surgery for peripheral arterial disease or abdominal aortic aneurysm.